银华国证港股通创新药ETF发起式联接C
(023930.jj ) 港股通创新药 (半年) 银华基金管理股份有限公司
基金经理马君基金类型指数型基金(ETF,联接型)成立日期2025-04-18总资产规模6.77亿 (2025-12-31) 基金净值1.2691 (2026-04-10) 管理费用率0.50%管托费用率0.10% (2026-04-09) 成立以来分红再投入年化收益率27.43% (717 / 5773)
备注 (0): 双击编辑备注
发表讨论

银华国证港股通创新药ETF发起式联接C(023930) - 历史基金净值数据曲线

最后更新于:2026-04-10

数据选项
加载中......
银华国证港股通创新药ETF发起式联接C历史净值,最多展示50条数据。
日期基金净值基金累计净值
2026-04-101.26911.2691
2026-04-091.26271.2627
2026-04-081.27781.2778
2026-04-071.30761.3076
2026-04-031.30901.3090
2026-04-021.30821.3082
2026-04-011.29231.2923
2026-03-311.21001.2100
2026-03-301.21961.2196
2026-03-271.20781.2078
2026-03-261.14531.1453
2026-03-251.16181.1618
2026-03-241.15091.1509
2026-03-231.11611.1161
2026-03-201.15581.1558
2026-03-191.17411.1741
2026-03-181.20351.2035
2026-03-171.18441.1844
2026-03-161.18051.1805
2026-03-131.14721.1472
2026-03-121.16611.1661
2026-03-111.18801.1880
2026-03-101.20521.2052
2026-03-091.16911.1691
2026-03-061.18501.1850
2026-03-051.13511.1351
2026-03-041.11151.1115
2026-03-031.13261.1326
2026-03-021.17421.1742
2026-02-271.21191.2119
2026-02-261.19581.1958
2026-02-251.24691.2469
2026-02-241.24841.2484
2026-02-131.25871.2587
2026-02-121.26131.2613
2026-02-111.28771.2877
2026-02-101.28611.2861
2026-02-091.25551.2555
2026-02-061.23351.2335
2026-02-051.23621.2362
2026-02-041.23311.2331
2026-02-031.22441.2244
2026-02-021.20881.2088
2026-01-301.25241.2524
2026-01-291.28341.2834
2026-01-281.29431.2943
2026-01-271.27491.2749
2026-01-261.26691.2669
2026-01-231.28891.2889
2026-01-221.27201.2720